Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
36.68
+0.58 (1.61%)
At close: Jun 8, 2026, 4:00 PM EDT
36.68
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,277,107
Market Cap
1.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 307 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Zymeworks | 243 |
RAPP News
- 9 hours ago - Rapport Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 5 days ago - Rapport Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Rapport Therapeutics price target raised to $65 from $53 at BTIG - TheFly
- 19 days ago - Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 21 days ago - Rapport Therapeutics assumed with a Buy at Truist - TheFly
- 4 weeks ago - Rapport Therapeutics reports Q1 EPS (42c), consensus (71c) - TheFly
- 4 weeks ago - Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Rapport Therapeutics Earnings release: Q1 2026 - Filings